118 related articles for article (PubMed ID: 18982184)
1. Venous thromboembolism clinically detected after hip fracture surgery with prophylaxis in a clinical practice setting.
Comp P; Happe LE; Sarnes M; Farrelly E
Am J Orthop (Belle Mead NJ); 2008 Sep; 37(9):470-5. PubMed ID: 18982184
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Shorr AF; Kwong LM; Sarnes M; Happe L; Farrelly E; Mody-Patel N
Thromb Res; 2007; 121(1):17-24. PubMed ID: 17449088
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.
Shorr AF; Sarnes MW; Peeples PJ; Stanford RH; Happe LE; Farrelly E
Am J Health Syst Pharm; 2007 Nov; 64(22):2349-55. PubMed ID: 17989444
[TBL] [Abstract][Full Text] [Related]
4. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery.
Lundkvist J; Bergqvist D; Jönsson B
Eur J Health Econ; 2007 Dec; 8(4):313-23. PubMed ID: 17225129
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
Sullivan SD; Kwong L; Nutescu E
Value Health; 2006; 9(2):68-76. PubMed ID: 16626410
[TBL] [Abstract][Full Text] [Related]
8. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
[TBL] [Abstract][Full Text] [Related]
9. Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.
Happe LE; Farrelly EM; Stanford RH; Sarnes MW
J Thromb Thrombolysis; 2008 Oct; 26(2):125-31. PubMed ID: 18034323
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
11. Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery.
Changolkar A; Menditto L; Shah M; Puto K; Farrelly E
Am J Health Syst Pharm; 2014 Apr; 71(7):562-9. PubMed ID: 24644116
[TBL] [Abstract][Full Text] [Related]
12. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
13. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Turpie AG
Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
17. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of dalteparin and enoxaparin in a hospital setting.
Carson W; Schilling B; Simons WR; Parks C; Choe Y; Faria C; Powers A
J Pharm Pract; 2012 Apr; 25(2):180-9. PubMed ID: 21987527
[TBL] [Abstract][Full Text] [Related]
19. Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis.
Di Mauro AL; Austin LJ; Zande J; Winckel K; Neale R; De Guzman KR
Blood Coagul Fibrinolysis; 2024 Apr; 35(3):101-107. PubMed ID: 38358899
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
